Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors.

Autor: Wong KK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Room T4-3900, Clinical Research Building, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. kkwong@mdanderson.org., Bateman NW; Gynecologic Cancer Center of Excellence, Department of Obstetrics and Gynecology, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA.; Henry M. Jackson Foundation for Advancement of Military Medicine, Inc., Bethesda, MD, USA., Ng CW; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Room T4-3900, Clinical Research Building, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Tsang YTM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Room T4-3900, Clinical Research Building, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Sun CS; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Room T4-3900, Clinical Research Building, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Celestino J; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Room T4-3900, Clinical Research Building, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Nguyen TV; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Room T4-3900, Clinical Research Building, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Malpica A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hillman RT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Room T4-3900, Clinical Research Building, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Zhang J; Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Futreal PA; Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rojas C; Gynecologic Cancer Center of Excellence, Department of Obstetrics and Gynecology, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA., Conrads KA; Gynecologic Cancer Center of Excellence, Department of Obstetrics and Gynecology, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA.; Henry M. Jackson Foundation for Advancement of Military Medicine, Inc., Bethesda, MD, USA., Hood BL; Gynecologic Cancer Center of Excellence, Department of Obstetrics and Gynecology, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA.; Henry M. Jackson Foundation for Advancement of Military Medicine, Inc., Bethesda, MD, USA., Dalgard CL; Department of Anatomy, Physiology and Genetics and Center for Military Precision Health, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Wilkerson MD; Department of Anatomy, Physiology and Genetics and Center for Military Precision Health, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Phippen NT; Gynecologic Cancer Center of Excellence, Department of Obstetrics and Gynecology, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA., Conrads TP; Women's Health Integrated Research Center at Inova Health System, Women's Service Line, Inova Fairfax Medical Campus, Falls Church, VA, USA.; Gynecologic Cancer Center of Excellence, Department of Obstetrics and Gynecology, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA., Maxwell GL; Women's Health Integrated Research Center at Inova Health System, Women's Service Line, Inova Fairfax Medical Campus, Falls Church, VA, USA.; Gynecologic Cancer Center of Excellence, Department of Obstetrics and Gynecology, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA., Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Room T4-3900, Clinical Research Building, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Gershenson DM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Room T4-3900, Clinical Research Building, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.

Publikováno v: Journal of translational medicine [J Transl Med] 2022 Dec 17; Vol. 20 (1), pp. 606. Date of Electronic Publication: 2022 Dec 17.

Differences in gynecologic tumor development in Amhr2-Cre mice with KRAS ^G12D or KRAS ^G12V mutations.

Autor: Kun EHS; Department of Gynecologic Oncology and Reproductive Medicine, Unit 1362, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Tsang YTM; Department of Gynecologic Oncology and Reproductive Medicine, Unit 1362, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Lin S; Department of Gynecologic Oncology and Reproductive Medicine, Unit 1362, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Pan S; Department of Gynecologic Oncology and Reproductive Medicine, Unit 1362, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Medapalli T; Department of Gynecologic Oncology and Reproductive Medicine, Unit 1362, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Malpica A; Departments of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Richards JS; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA., Gershenson DM; Department of Gynecologic Oncology and Reproductive Medicine, Unit 1362, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Wong KK; Department of Gynecologic Oncology and Reproductive Medicine, Unit 1362, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. kkwong@mdanderson.org.

Publikováno v: Scientific reports [Sci Rep] 2020 Nov 26; Vol. 10 (1), pp. 20678. Date of Electronic Publication: 2020 Nov 26.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A cautionary note on the use of N-acetylcysteine as a reactive oxygen species antagonist to assess copper mediated cell death.

Autor: Graham, Rebecca E.¹ (AUTHOR), Elliott, Richard J. R.² (AUTHOR), Munro, Alison F.² (AUTHOR), Carragher, Neil O.² (AUTHOR) N.Carragher@ed.ac.uk

Publikováno v: PLoS ONE. 12/11/2023, Vol. 18 Issue 12, p1-11. 11p.